This image provided by Gilead Sciences shows a bottle of the Hepititis drug Harvoni. Harvoni, the newest pill from California-based Gilead Sciences, accounted for more than three-fourths of the prescriptions filled for hepatitis-C drugs in the first three months of this year, according to IMS Health.
{}